Treatment for Severe Frostbite to Prevent Amputatio
Dr. Peter Hackett, a seasoned cold-weather injury specialist, has been on the frontlines of treating frostbite since 1971. His dedication to patient care and research has led to groundbreaking advancements in the field.
In the past, patients with severe frostbite faced limited treatment options, such as rewarming, amputation, or simply waiting for auto-amputation to occur. However, a recent development has given hope to those suffering from this debilitating condition – the FDA has approved the use of iloprost, the first therapy for severe frostbite in the United States.
Iloprost, administered intravenously over a little more than a week, works by improving circulation, limiting inflammation, and preventing further tissue damage. This groundbreaking drug offers a new ray of hope for patients experiencing severe frostbite, which commonly affects the toes, fingers, ears, cheeks, and nose.
Dr. Hackett and his team are optimistic about the potential of iloprost to significantly improve outcomes for patients with severe frostbite in the future. Their tireless efforts and dedication to advancing treatment options for cold-weather injuries are bringing us one step closer to better care and recovery for those in need.
